Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

[Clinical practice guidelines for the diagnosis, treatment, and prevention of Helicobacter pylori infection in Chinese adults].

Created on 10 Jul 2026

Authors

Helicobacter pylori Study Group, Chinese Society of Gastroenterology, Chinese Medical Association

Published in

Zhonghua nei ke za zhi. Volume 65. Issue 7. Pages 651-680. Jul 01, 2026.

Abstract

Helicobacter pylori infection remains a significant public health concern in China. Effective prevention and control require a coordinated "three-in-one" approach encompassing standardized expert recommendations, consistent physician implementation, and active patient participation. However, comprehensive, systematic, and scientifically robust clinical practice guidelines for Helicobacter pylori infection to support clinical decision-making have been lacking. This guideline adopts a "from practice to practice" development framework, systematically identifying key clinical questions through extensive investigation and adhering to rigorous methodological standards to formulate practical, evidence-based recommendations. The multidisciplinary expert panel, incorporating perspectives from front-line clinicians, ensures that recommendations address real-world considerations, including resource availability, operational feasibility, and social ethics of healthcare. The development of this guideline directly addresses the critical bottleneck of the disconnect between consensus guidelines and clinical practice in current treatment and prevention efforts. While upholding the rigorous evidence-based medicine principle, it innovatively integrates with clinical practice needs, transforming complex bodies of professional evidence into clear, concise, and actionable key points. This guideline includes 45 key clinical topics and aims to serve as a bridge between professional medical evidence and healthcare practice, promote standardized, uniform clinical services, and enhance the overall prevention and control of Helicobacter pylori infection in China.

PMID:
42427040
Bibliographic data and abstract were imported from PubMed on 10 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 10
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement